» Authors » Sam H Whiting

Sam H Whiting

Explore the profile of Sam H Whiting including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarchoan M, Powderly J, Bastos B, Karasic T, Crysler O, Munster P, et al.
Cancer Res Commun . 2024 Mar; 4(4):1100-1110. PMID: 38551394
Purpose: TPST-1120 is a first-in-class oral inhibitor of peroxisome proliferator-activated receptor α (PPARα), a fatty acid ligand-activated transcription factor that regulates genes involved in fatty acid oxidation, angiogenesis, and inflammation,...
2.
Coveler A, Pillarisetty V, Koh W, Zhen D, Park J, King G, et al.
Pancreas . 2023 Oct; 52(5):e282-e287. PMID: 37782886
Objectives: Pancreatic ductal adenocarcinoma (PDA) is the third most common cause of cancer death in the United States. Most patients who undergo resection develop recurrence. Standard treatment confers a median...
3.
Meric-Bernstam F, Tannir N, Iliopoulos O, Lee R, Telli M, Fan A, et al.
Clin Cancer Res . 2022 Feb; 28(8):1540-1548. PMID: 35140121
Purpose: Dual inhibition of glucose and glutamine metabolism results in synergistic anticancer effects in solid tumor models. Telaglenastat, an investigational, small-molecule, glutaminase inhibitor, exhibits modest single-agent activity in renal cell...
4.
Harding J, Telli M, Munster P, Voss M, Infante J, DeMichele A, et al.
Clin Cancer Res . 2021 Jul; 27(18):4994-5003. PMID: 34285061
Purpose: Glutamine is a critical fuel for solid tumors. Interference with glutamine metabolism is deleterious to neoplasia in preclinical models. A phase I study of the oral, first-in-class, glutaminase (GLS)...